Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone in Critically Ill Patients With Hyperinflammatory Phenotype
NCT07511582Phase 2Recruiting
- Sponsor
- Bin Du
- Start
- Apr 2026
- Primary completion
- Apr 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methylprednisolone injection in sepsis, acute respiratory distress syndrome (ARDS), sponsored by Bin Du. Started Apr 2026; status: recruiting.
02
Drugs
methylprednisolone injection
03
Conditions
sepsisacute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT07511582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07511582.